Stent thrombosis in patients with chronic kidney disease

Michael Donahue1, Carlo Briguori

  • 1Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy.

Insights

Patients with chronic kidney disease face higher risks of stent thrombosis (ST) after percutaneous coronary intervention. This review examines evidence on ST with drug-eluting stents in this high-risk population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Chronic kidney disease (CKD) significantly increases the risk of adverse cardiac events, including death and myocardial infarction.
  • Stent thrombosis (ST), a severe complication after percutaneous coronary intervention (PCI), remains a concern despite advances in treatment.
  • Identifying high-risk patients for ST is crucial for developing effective preventive strategies.

Purpose of the Study:

  • To review the existing evidence on stent thrombosis (ST) in patients with chronic kidney disease (CKD).
  • To evaluate the safety and efficacy of drug-eluting stents (DES) in this specific patient group.
  • To highlight the need for improved risk stratification and prevention of ST in CKD patients undergoing PCI.

Main Methods:

  • Comprehensive literature search for studies on ST, PCI, drug-eluting stents, and chronic kidney disease.
  • Analysis of data regarding the incidence, risk factors, and outcomes of ST in CKD patients.
  • Synthesis of evidence to assess the role of DES in managing ST risk in this population.

Main Results:

  • CKD is a well-established predictor of adverse cardiac events post-PCI.
  • While new therapies have reduced ST rates, it remains a significant cause of morbidity and mortality.
  • Evidence regarding the specific impact of DES on ST in CKD patients requires further examination.

Conclusions:

  • Despite therapeutic advancements, stent thrombosis (ST) continues to pose a serious threat to patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention.
  • Further research is needed to refine preventive strategies and identify high-risk CKD patients susceptible to ST, particularly concerning the use of drug-eluting stents.
  • Optimizing management of CKD patients undergoing PCI is essential to mitigate the risk of life-threatening stent thrombosis.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...